Adamed Pharma S.A.

The Adamed Group is a Polish pharmaceutical and biotechnology company manufacturing over 250 products offered to patients in 60 countries around the world. Currently, it has 1,600 employees. Since 2001, the company has invested EUR 225 million in research and development. It establishes scientific research consortia with leading universities and scientific institutes. The company’s intellectual property is protected by over 90 patents. The Adamed Group is rated by among ten largest pharmaceutical companies operating in Poland (source: IMS Health). The company is also a strategic partner of a new Polish telemedicine platform Medivio.
The history of the Adamed Group is the story of responding to key challenges of modern medicine. This is our mission as well as the direction we have been taking consistently since 1986. Every day, we work with over 150 scientists on innovative research projects, we perfect the existing therapies and promote healthy lifestyle and disease prevention.
This makes the Adamed Group the leader in the Polish market of new generation drugs.
The Adamed Group focuses on working towards innovative solutions in the field of pharmacology, meanwhile gaining the position of the Polish leader of innovation.
The Adamed Group R&D Centre is dedicated to research projects aiming at the development of generic and innovative drugs, which involve organic synthesis, new innovative technologies and support through physicochemical analyses. The Centre is used for projects in laboratory and semitechnical phase, after which the technologies may be transferred to Adamed Group manufacturing plants.
Thanks to the efforts of R&D laboratory experts, the latest technological achievements and cutting edge equipment, both basic and original drug forms, such as multilayer tablet or tablet-in-capsule, are being developed. Innovative analytical solutions applied also make our research projects unique. Cutting-edge laboratory equipment, including SEM, XRPD and UPLC/MS, as well as expertise and experience place us in the forefront of pharmaceutical companies for which innovation in research and development is of key importance.
In the era of globalisation and strong competition, product quality plays an essential role, in addition to optimal production costs and high customer service level. The Modern Production and Logistics Centre is located in the region of Łódź. It is characterised by high growth and effectiveness dynamics, which may be expressed in several parameters.
The Centre includes, among others, a closed zone for the production of steroids and cancer drugs, with necessary technological equipment worth about EUR 5 million. It is also a showpiece facility for the region of Łódź as well as a stable employer of highly-qualified
staff. Implementation of good practices used in other sectors, where broadly defined supply chain management is vital for gaining competitive edge, plays a major role.

We follow EU initiatives, policies and legislative files related to our pharmaceutical and consumer businesses. This includes topics such as R&D and clinical trials, data protection, pharmaceutical legislation, mHealth, public health, medical devices, trade& IP, environment.

2

0.5

No lobbyists with EP accreditations

None declared

Mr Maciej Adamkiewicz (Prezes Adamed Pharma)

Mr Maciej Adamkiewicz (Prezes Adamed Pharma)

II - In-house lobbyists and trade/business/professional associations

Companies & groups